Bhutan is a rapidly growing economy that is transitioning from international donor support. As such, the country is looking for ways to ensure that they continue to provide the adequate services and support for their population in a rational and sustainable manner. Bhutan has begun using health tech

Abstract Background: Diarrhoea remains one of the top ten causes of under-five child morbidity in Bhutan, and rotavirus is a significant cause of child diarrhoeal hospitalisations. This study sought to determine the health outcomes, cost-effectiveness, and budget and human resource implications o

This study aimed to evaluate cost-effectiveness of peritoneal dialysis (first policy) and freely chosen of dialysis modality. Decision analysis model was constructed for cost effectiveness analysis. Parameters in the model were obtained from the literature review and Thailand Renal Replacement Therapy (TRT) registry database analysis.  201-357-25

Economic Evaluation of Rehabilitation Services for Inpatients with Stroke in Thailand: A Prospective Cohort Study. Orathai Khiaocharoen, BN, PhD1, , , , Supasit Pannarunothai, MD, PhD2, Wachara Riewpaiboon,MD3, Lily Ingsrisawang, BSc, PhD4, Yot Teerawattananon, MD, PhD5 1 Hea

A cost-utility analysis was performed to estimate the costs and quality adjusted life year (QALY) of HIV prevention program compared to only existing programs. This analysis focused on both the general population and high risk populations. This study found that the incremental cost effectiveness ratio of HIV vaccination was most sensitive to change

Economic Evaluation of Policy Options for Prevention and Control of Cervical Cancer in Thailand Naiyana Praditsitthikorn,1,2 Yot Teerawattananon,1,3 Sripen Tantivess,1,3 Supon Limwattananon,3 Arthorn Riewpaiboon,2 Saibua Chichareon,4 Nantakan Ieumwananonthachai5 and Viroj Tangcharoensathien3

Abstract Objectives This study aims to assess the value for money and budget impact of offering hemodialysis (HD) as a first-line treatment, or the HD-first policy, and the peritoneal dialysis (PD) first policy compared to a supportive care option in patients with end-stage renal disease (ESRD)

Economic evaluation of introducing maternal pertussis vaccination into the national vaccination programme.

Abstract BACKGROUND: Pegylated interferon alpha 2a, alpha 2b and ribavirin have been included to the National List of Essential Medicines (NLEM) for treatment of only chronic hepatitis C genotypes 2 and 3 in Thailand. This reimbursement policy has not covered for other genotypes of hepatitis